We offer the full array of blood and marrow transplantation services including autologous, allogeneic, myeloablative and reduced intensity transplant depending on the type and stage of disease.

In addition to offering transplants to patients with acute and chronic leukemias, myeloproliferative and myelodysplastic disorders, we have a particular focus on patients with lymphomas (Non-Hodgkin/Hodgkin Lymphoma), Plasmacell dyscrasias (Amyloidosis and Multiple Myeloma) and Sickle Cell Disease. The BMT program at Columbia University Medical Center is closely integrated with the primary referring disease centers at Columbia (i.e. Amyloidosis and Myeloma Service, Center for Lymphoid Malignancies, MDS Center, Leukemia Service) and works closely with the referring oncologists outside of Columbia in order to provide the most cohesive and integrated continuity of care for our transplant patients.